Alkermes Inc acquires Enzytech Inc


Alkermes acquired all the outstanding capital stock of Enzytech in exchange for #.# mil common shares valued at $##.## mil. Shareholders received .#### share per each common share held, #.## shares for each share of convertible preferred

Deal Information

Credit & Investment Research

Market Research

News